Ropirio Therapeutics, Inc.
Biotechnology Research
This Need Is Immense
4 employees
- Employees
- 4
- Contacts
- 2
- Emails
- 2
- Phones
- 2
Ropirio Therapeutics, Inc. Overview
- Headquarters
- This Need Is Immense
- Industry
- Biotechnology Research
- Employees
- 4
- Founded
- 2023
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Ropirio Therapeutics, Inc.
Over the past decade, there has been an explosion of research uncovering the critical role the lymphatic system plays in serious diseases affecting more than 500 million people globally. The opportunity to address this need is immense, and Ropirio is at the forefront, having identified the first target that activates the lymphatic system. This activation improves lymphatic flow, modulates inflammation, and prevents fibrosis. Ropirio is singularly focused on developing the first lymphatic medicines to improve patients’ lives.
Ropirio Therapeutics, Inc. Contact Details
- People in AeroLeads
- 2
- With contact data
- 2
- Email contacts
- 2
- 100.0% coverage
- Phone contacts
- 2
- 100.0% coverage
Ropirio Therapeutics, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Sangeeta Bhatia | Mit Professor & Entrepreneur | Cambridge, Massachusetts, United States |
Email
Phone
|
| Jerald Korn | CEO at Ropirio Therapeutics | Cambridge, Massachusetts, United States |
Email
Phone
|
Compare Similar Companies to Ropirio Therapeutics, Inc.
BioIVT
Biotechnology Research
Wyss Institute at Harvard University
Biotechnology Research
Sunbird Bio
Biotechnology Research
Satellite Bio
Biotechnology Research
Vironexis Biotherapeutics
Biotechnology Research
Amplifyer Bio
Biotechnology Research
Matrisome Bio
Biotechnology Research
Port Therapeutics
Biotechnology Research
Hepregen Corporation
Biotechnology Research
Inaya Therapeutics
Biotechnology Research